Search Results - "Alahmari, Bader"

Non‐myeloablative human leukocyte antigen‐matched related donor transplantation in sickle cell disease: outcomes from three independent centres by Alzahrani, Mohsen, Damlaj, Moussab, Jeffries, Neal, Alahmari, Bader, Singh, Avani, Rondelli, Damiano, Tisdale, John F., Saraf, Santosh L., Hsieh, Matthew M.

“…Summary Non‐myeloablative haematopoietic progenitor cell transplantation (HPCT) from matched related donors (MRD) has been increasingly utilized in sickle cell…”
Get full text

Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease by Choi, Jaebok, Cooper, Matthew L., Staser, Karl, Ashami, Kidist, Vij, Kiran R., Wang, Bing, Marsala, Lynne, Niswonger, Jessica, Ritchey, Julie, Alahmari, Bader, Achilefu, Samuel, Tsunoda, Ikuo, Schroeder, Mark A., DiPersio, John F.

“…The therapeutic benefits of allogeneic hematopoietic stem cell transplantation (allo-HSCT) are derived from the graft-versus-leukemia (GvL) effects of the…”
Get full text

Pharmacologic blockade of JAK1/JAK2 reduces GvHD and preserves the graft-versus-leukemia effect by Choi, Jaebok, Cooper, Matthew L, Alahmari, Bader, Ritchey, Julie, Collins, Lynne, Holt, Matthew, DiPersio, John F

“…We have recently reported that interferon gamma receptor deficient (IFNγR-/-) allogeneic donor T cells result in significantly less graft-versus-host disease…”
Get full text

Selective targeting of α4β1 integrin attenuates murine graft versus host disease by Alahmari, Bader, Cooper, Matthew L., Vij, Kiran, Ritchey, Julie, Ruminski, Peter, Gao, Feng, Choi, Jaebok, DiPersio, John F.

Get full text

Favorable outcome of non‐myeloablative allogeneic transplantation in adult patients with severe sickle cell disease: A single center experience of 200 patients by Damlaj, Moussab, Alahmari, Bader, Alaskar, Ahmed, Alhejazi, Ayman, Alsadi, Husam, Ahmed, Mazin, Alanazi, Tahani, Ahmed, Rasha, Alharbi, Amani, Shehabeddine, Inaam, Alzaidi, Afnan, Alkhuraisat, Suha, Mahassnah, Isam, Alquraan, Hamza, Ballili, Maybelle, Alzahrani, Mohsen

“…Allogeneic hematopoietic stem cell transplant (HSCT) for adults with severe sickle cell disease (SCD) is potentially curative but not commonly utilized therapy…”
Get full text

Brentuximab vedotin containing salvage followed by consolidation post autologous hematopoietic stem cell transplantation in high risk relapsed refractory classical Hodgkin lymphoma by Damlaj, Moussab, Abuelgasim, Khadega A., Alhejazi, Ayman, Alahmari, Bader, Alaskar, Ahmed, Alzahrani, Mohsen

Get full text

Peripheral hematopoietic stem cell mobilization utilizing growth factors in donors with sickle cell trait is safe and effective by Damlaj, Moussab, Alaskar, Ahmed, Ghazi, Samer, Alahmari, Bader, Alhejazi, Ayman, Al-Zahrani, Mohsen

Get full text

Selective targeting of histone modification fails to prevent graft versus host disease after hematopoietic cell transplantation by Alahmari, Bader, Cooper, Matthew, Ziga, Edward, Ritchey, Julie, DiPersio, John F, Choi, Jaebok

“…Allogeneic hematopoietic cell transplantation is often complicated by graft versus host disease (GvHD), primarily mediated through allo-reactive donor T cells…”
Get full text

HLA-identical related hematopoietic stem cell transplantation in severe sickle cell disease: age is not a barrier to successful outcome by Alzahrani, Mohsen, Damlaj, Moussab, Essa, Mohammed, Alahmari, Bader, Alaskar, Ahmed, Hejazi, Ayman, Basher, Enas, Alsadi, Husam, Ahmed, Mazin, Abujoub, Rodaina, Ghazi, Samer, Alshobaki, Heba, Abuelgasim, Khadega, Salama, Hind, Gmati, Giamal, Alsultan, Abdulrahman

Get full text

Feasibility of early sirolimus cessation post non-myeloablative transplantation in adult patients with severe sickle cell disease by Damlaj, Moussab, Alahmari, Bader, Alaskar, Ahmed, Alhejazi, Ayman, Alsadi, Husam, Shehab-Eddine, Inaam, Alghamdi, Abdulrahman, Almashaqbeh, Walid, Alshobaki, Heba, Mahasneh, Isam, Alotaibi, Ashwaq, Alanazi, Tahany, Balili, Maybelle, Quarshi, Mohammed, Ahmed, Mazin, Alzahrani, Mohsen

Get full text

Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma by Abuelgasim, Khadega A., Alzahrani, Mohsen, Alsharhan, Yousef, Khairi, Moataz, Hommady, Mohammed, Gmati, Giamal, Salama, Hind, Ali, Osama, Alahmari, Bader, Masuadi, Emad M., Alaskar, Ahmed, Alhejazi, Ayman, Damlaj, Moussab

Get full text

Clinical course and outcomes of COVID‐19 in hematopoietic cell transplant patients, a regional report from the Middle East by El Fakih, Riad, Haroon, Alfadil, Alfraih, Feras, Al-Khabori, Murtadha K., Alzahrani, Mohsen, Alhuraiji, Ahmad, Hamadah, Abdulaziz, AlJohani, Naif I., Alahmari, Bader, Essa, Mohammed F., Motabi, Ibraheem H., Tailor, Imran K., Almaghrabi, Reem S., Al-Farsi, Khalil, Abosoudah, Ibraheem, Ayas, Mouhab, Elhassan, Tusneem A., Suhebeh, Ashraf M., Ahmed, Syed Osman, Alhayli, Saud, Kaloyannidis, Panayotis, Alsaeed, Ahmad, Anezi, Khalid Al, Alamoudi, Sameer, Damlaj, Moussab, Hashmi, Hani Al, Aljurf, Mahmoud

“…The coronavirus disease‐2019 (COVID‐19) caused by SARS Coronavirus 2 (SARS‐CoV‐2) is a potentially lethal infection. Cancer patients, and specifically…”
Get full text

Therapeutic Potential of Checkpoint Inhibitors in Refractory Plasmablastic Lymphoma by Damlaj, Moussab, Alzayed, Mohammed, Alahmari, Bader, Alhejazi, Ayman, Alaskar, Ahmed, Alzahrani, Mohsen

Get full text

Infectious complications in adult sickle cell anemia patients undergoing hematopoietic stem cell transplantation by Abuelgasim, Khadega A., Damlaj, Moussab, Bosaeed, Mohammad, Altamimi, Sumayyah, Abdullah, Hind, Ramli, Reem M., Alzahrani, Rahma, Alzughaibi, Nourah, Alahmari, Bader, Alhejazi, Ayman, Alaskar, Ahmed, Alzahrani, Mohsen

Get full text

Post-CD19 Chimeric Antigen Receptor T-Cell Therapy Cytomegalovirus Retinitis by Bin Dokhi, Haifa, Alharbi, Amjad O, Ibnouf, Nida H, Alahmari, Bader, Refka, Mohammed N

“…The purpose of this case report was to present a case of cytomegalovirus (CMV) retinitis in a patient with diffuse large B-cell lymphoma (DLBCL) post-CD19…”
Get full text

Incidence of ocular manifestations in patients with graft versus host disease after allogeneic stem cell transplant in Riyadh, Saudi Arabia by Aldebasi, Tariq, Gangadharan, Shiji, Shaheen, Naila A., Alhussain, Basil, Almudhaiyan, Tariq, Alahmari, Bader

“…AIM: To evaluate the incidence and severity of ocular graft versus host disease (oGVHD) in patients who underwent allogeneic stem cell transplant (SCT) in King…”
Get full text

Pro106Leu MPL mutation is associated with thrombocytosis and a low risk of thrombosis, splenomegaly and marrow fibrosis by Alzahrani, Musa, Al Turki, Saeed, Al Rajban, Waleed, Alshalati, Fatimah, Almodaihsh, Fahad, Abuelgasim, Khadega A., Alahmari, Bader, Al Bogami, Thamer, Ali, Osama, Al Harbi, Talal, AlBalwi, Mohammed A., Alotaibi, Maram, Aleem, Aamer, Al Asker, Ahmed, Al Mugairi, Areej

“…The P106L mutation in the human myeloproliferative leukemia virus oncogene (MPL) was shown to be associated with hereditary thrombocythemia in Arabs. The…”
Get full text

Comparing Invasive Pulmonary Aspergillosis Mortality Between Liposomal Amphotericin B and Voriconazole in Patients With Hematological Malignancy or Hematopoietic Stem Cell Transplantation by Mahmoud, Ebrahim, Alzahrani, Mohsen, Loutfi, Shukri, Alqahatani, Hajar Y, Bosaeed, Mohammad, Ahmed, Ayoub, Alahmari, Bader, Alsadi, Husam, Ahmed, Mazin, Al Dhoayan, Mohammed

“…Objectives We evaluated liposomal amphotericin B versus voriconazole for the treatment of invasive pulmonary aspergillosis (IPA) in patients with hematological…”
Get full text

Management Approach to Acute Myeloid Leukemia Leveraging the Available Resources in View of the Latest Evidence: Consensus of the Saudi Society of Blood and Marrow Transplantation by Alahmari, Bader, Alzahrani, Mohsen, Al Shehry, Nawal, Tawfiq, Osamah, Alwasaidi, Turki, Alhejazi, Ayman, Bakkar, Mohammed, Al Behainy, Amal, Radwi, Mansour, Alaskar, Ahmed

“…PURPOSE Acute myeloid leukemia (AML) is the most prevalent acute leukemia in adults and is responsible for the majority of cancer-related mortality. In Saudi…”
Get full text

Impact of cluster of differentiation 20 expression and rituximab therapy in classical Hodgkin lymphoma: Real world experience by Abuelgasim, Khadega A., Shammari, Raed Al, Alshieban, Saeed, Alahmari, Bader, Alzahrani, Mohsen, Alhejazi, Ayman, Alaskar, Ahmed, Damlaj, Moussab

“…The prognostic impact of CD20 expression and rituximab therapy in classical Hodgkin lymphoma (cHL) is unclear. Among 310 patients, CD20 was expressed in 66…”
Get full text